@article{727a3c9b133d4c838928c44b55637248,
title = "Comparison of Biodistributions and Therapeutic Efficacies of Pretargeted Radioimmunoconjugates Targeting the CD20, CD22, and DR Molecules on Human B Cell Lymphomas.",
author = "Anastasia Pantelias and Pagel, \{John M.\} and Nathan Hedin and Yukang Lin and Donald Axworthy and Theodore, \{Louis J.\} and Press, \{Oliver W.\}",
note = "Pretargeted radioimmunotherapy (PRIT) using streptavidin (SA)-conjugated antibodies (Abs), followed by clearing agent and radiolabeled biotin is a promising method that can increase the effectiveness of RIT, while decreasing the toxicities associated with directly labeled Abs. Although CD20 has been the traditional target antigen for RIT of non-Hodgkin lymphoma (NHL), studies targeting HLA DR and CD22 have yielded promising results.",
year = "2005",
month = nov,
day = "16",
language = "American English",
volume = "106",
journal = "Blood",
}